Sulfonylurea-glitazone combinations for diabetes

Details Sulfonylurea-glitazone combinations for diabetes Sulfonylurea-glitazone combinations for diabetes

1997-11-13

1999-01-12

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514593, 514866, A61K 31425, A61K 31175

Patent

active

058590374

ABSTRACT:
Combinations of a sulfonylurea antidiabetic agent and a glitazone antidiabetic agent are useful for treating diabetes mellitus and improving glycemic control.

REFERENCES:
Today's News, "Rezulin(R) (troglitazone) . . . ", 1997, pp. 1-3.
Oakes et al., "A New Antidiabetic Agent . . . ", Diabetes vol. 43, 1994 p. 1203.
Hulin et al., "The Glitazone Family . . . ", Current Pharm. Design. 1996, vol. 2, No. 1, pp. 85-.
Groop et al., "Sulfonylureas in NIDDM", Diabetes Care, 1992, vol. 15, No. 6, pp. 737-754.
Nakano et al., CS-045, "Clinical Evaluation . . . ", English Transl. No. 138-007, pp. 1-38 (1993).

Affiliated with

Also associated with

Rating

Sulfonylurea-glitazone combinations for diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfonylurea-glitazone combinations for diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonylurea-glitazone combinations for diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1516387